Skip to main content
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 3, 2011

Articles

Favourites:
ADD
Favourites:
ADD

New Features that Improve the Pharmacophore Tools from Accelrys
pp. 173-180(8)
Authors: Sutter, Jon; Li, Jiabo; J. Maynard, Allister; Goupil, Anne; Luu, Tien; Nadassy, Katalin

Favourites:
ADD

Receptor-Based Pharmacophore and Pharmacophore Key Descriptors for Virtual Screening and QSAR Modeling
pp. 181-189(9)
Authors: Dong, Xialan; O. Ebalunode, Jerry; Yang, Sheng-Yong; Zheng, Weifan

Favourites:
ADD

High Content Pharmacophores from Molecular Fields: A Biologically Relevant Method for Comparing and Understanding Ligands
pp. 190-205(16)
Authors: J. Cheeseright, Timothy; D. Mackey, Mark; A. Scoffin, Robert

Favourites:
ADD

Why so Few Drug Targets: A Mathematical Explanation?
pp. 206-213(8)
Authors: Tun, Kyaw; Menghini, Marta; D'Andrea, Lina; Dhar, Pawan; Tanaka, Hiroshi; Giuliani, Alessandro

Favourites:
ADD

Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators
pp. 214-227(14)
Authors: Wang, Zhanli; Huo, Jianxin; Sun, Lidan; Wang, Yongfu; Jin, Hongwei; Yu, Hui; Zhang, Liangren; Zhou, Lishe

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content